课题基金 / 基金详情

Workshop: Exploring Quantitative Approaches to Clinical Cancer Data; February 13-18, 2015, Princeton, New Jersey

Workshop: Exploring Quantitative Approaches to Clinical Cancer Data; February 13-18, 2015, Princeton, New Jersey
研讨会:探索临床癌症数据的定量方法;
批准号:
1502537
负责人:
Sung Poblete
金额:
$19.8万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-01-15 至 2015-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
在过去的五到十五年里,应用于生物问题的技术取得了显著的进步。这导致了对基因组、RNA种类、蛋白质功能和修饰的定量测量,以及对细胞功能的表观遗传调节。使用这些新技术已经组装了极大的信息数据库。生物学中应用这些技术最快的领域之一发生在癌症研究中。基于定量的分析在了解癌症的原因、途径、诊断、预后和治疗方面正变得越来越重要。通常,生物学家和临床医生缺乏从这些大型数据集中提取有用信息所需的复杂分析水平所需的数学、物理、计算机科学和化学方面的广泛技能。来自多个学科的定量研究人员已经进入生物学领域,探索这些基础科学挑战,但他们往往很少或根本没有接受过癌症生物学领域的培训,对该领域的重要生物学问题也知之甚少。这两个小组之间的合作的好处开始在癌症研究中得到解决和观察,但协同合作的速度和全面承诺仍然是一个挑战。SU2C将汇集在生物研究和临床肿瘤学家方面拥有强大背景的理论物理学家、数学家和计算机科学家,这两个群体的研究领域传统上并不交叉,以开发一个整合数学和计算方法以及临床癌症研究的研究项目。SU2C将组织一个思想实验室,将这些研究人员带到住宅研究环境中,进行为期数天的思想、方法和知识交流,以开发这样的综合研究项目。目标是召集3到4个临床肿瘤学家和量化科学家团队,以解决临床癌症研究数据中出现的重要问题或问题。这些方法将由IDEAS实验室的科学家团队或小组在简短的初步提案中阐明。然后将对提案进行细化,并可能要求团队中的更多成员参与。然后,可以提交这些提案,以便可能从公共和私人来源获得资金。因此,IDEAS实验室拥有一套智力和潜在的实用成果,导致使用临床研究数据来探索最佳的想法和量化方法。将来自上述两个群体的高度成功的个人聚集在一起,目的是联合教育这两个群体,并开发定量和临床癌症研究相结合的研究项目,可以预期导致癌症研究中基础科学问题的新方法的发展。这一努力有可能开创一个新的研究领域,解决我们对疾病的起源、进展、诊断、预后、治疗和患者疾病结局的理解。反过来,这又有可能降低社会开发有效治疗方法的成本,提高癌症患者的生活质量和结局。可能实现的益处类型包括:1)改进技术和工具以生成稳健的定量生物学数据;2)使用严格的数学方法捕获和表示高维基因组数据--这些表示可以帮助识别标记以对患者分层并识别潜在的治疗靶点;3)整合不同类型的大规模癌症数据;4)生成工具以识别大数据集中的潜在治疗靶点,而不是单基因改变的复发;例如,使用大规模基因组数据识别不同基因之间的协同活动,以及5)使用基因组数据提供关于肿瘤进化的可测试的定量模型;特别是,从纵向和横截面基因组数据重建肿瘤的进化史。
英文摘要
The past five to fifteen years have seen remarkable advances in the technologies applied to biological problems. This has resulted in quantitative measurements of genomes, RNA species, protein functions and modifications, and epigenetic regulation of cellular functions. Extremely large databases of information have been assembled using these new technologies. Among the most rapid areas of biology to apply these technologies has occurred in cancer research. Quantitative based analysis is becoming increasingly important to understand the causes, pathways, diagnosis, prognosis and treatment of cancer. Commonly, biologists and clinicians lack the extensive skills in mathematics, physics, computer science, and chemistry that are required for the sophisticated levels of analysis that are needed to extract useful information from these large datasets. Quantitative researchers from an array of disciplines have entered the field of biology to explore these basic science challenges, but they often have little or no prior training in the field of cancer biology, and little understanding of the important biological questions in the field. The benefits of collaboration between these two groups are starting to be addressed and observed in cancer research, but the pace and full promise of synergistic collaboration remains a challenge. SU2C will bring together theoretical physicists, mathematicians, and computer scientists with strong backgrounds in biological research and clinical oncologists, two groups whose research fields do not traditionally intersect, in order to develop a research project integrating mathematical and computational approaches and clinical cancer research. SU2C will organize an Ideas Lab to bring these researchers to a residential research setting for a multi-day exchange of ideas, methods, and knowledge, to develop such integrated research projects. The goal is to assemble 3 to 4 teams of clinical oncologists and quantitative scientists to address important problems or questions that arise from clinical cancer research data. These approaches will be articulated in short preliminary proposals by teams or groups of scientists at the Ideas Lab. The proposals will then be refined and additional members of a team may be asked to participate. The proposals may then be submitted for possible funding from public and private sources. Thus, the Ideas Lab has both an intellectual and potential practical set of outcomes, resulting in the best ideas and quantitative approaches being explored employing clinical research data.Bringing together highly accomplished individuals from the two groups outlined above, for the purpose of jointly educating both groups and developing research projects at the convergence of quantitative and clinical cancer research, can be expected to lead to the development of novel approaches to fundamental science questions in cancer research. This effort has the potential to create a new field of research that can address our understanding of disease origin, progression, diagnosis, prognosis, treatment and the outcome of disease in patients. This, in turn, has the potential to lower the costs to society of developing effective therapeutic treatments, of enhancing quality of life and the outcome for cancer patients. The types of benefit that may be realized include the possibility of: 1) refining the technologicaltools to generate robust quantitative biological data; 2) capturing and representing high dimensional genomic data using rigorous mathematical approaches - these representations can help to identify markers to stratify patients and to identify potential therapeutic targets; 3) integrating different types of large scale cancer data; 4) generating tools to identify potential therapeutic targets in large datasets beyond recurrence of single gene alterations; for instance, identifying synergistic activities between different genes using large scale genomic data, and 5) providing quantitative testable models about the evolution of tumors using genomic data; in particular, reconstructing the evolutionary history of tumors from longitudinal and cross sectional genomic data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Exploring Changing Fertility Intentions in China
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    MINHEE CHAE
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位: